Nicotinamide restores phosphaturic effect of PTH and calcitonin in phosphate deprivation.
Results of previous studies suggest a potentially important role for nicotinamide adenine dinucleotide (NAD) in the cellular regulation of phosphate transport by the renal proximal tubules. The present clearance studies were performed to evaluate whether intraperitoneal administration of nicotinamide, a precursor of NAD and inhibitor of NAD catabolism, would not only increase phosphate excretion but also restore the phosphaturic response to parathyroid hormone (PTH) in rats fed a low phosphate diet. Rats fed a low phosphate diet were resistant to the phosphaturic effect of PTH, calcitonin, and dibutyryl cAMP (DBcAMP) in spite of the fact that all three agents elicited an increase in the urinary excretion of cAMP. Administration of nicotinamide to rats fed a low phosphate diet increased renal cortical NAD levels, increased phosphate excretion, partially restored the phosphaturic effect of PTH and DBcAMP, and completely restored the phosphaturic response to calcitonin. We conclude that nicotinamide restores the phosphaturic effect of PTH and calcitonin in rats fed a low phosphate diet by acting at a cellular step subsequent to cAMP generation to inhibit tubular reabsorption of phosphate.
D000818:Animals; D003994:Bucladesine / Q000502:physiology; D002116:Calcitonin / Q000502:physiology*; D004032:Diet; D008297:Male; D009536:Niacinamide / Q000494:pharmacology*; D010281:Parathyroid Hormone / Q000502:physiology*; D010710:Phosphates / Q000502:physiology / Q000652:urine*; D051381:Rats; D011919:Rats, Inbred Strains
D010281:Parathyroid Hormone; D010710:Phosphates; D009536:Niacinamide; D003994:Bucladesine; D002116:Calcitonin